 Sanofi SA NASDAQ: SNY and Translate Bio Inc NASDAQ: TBIO have started a human trial of their mRNA COVID-19 vaccine candidate, dubbed MRT5500. The event has triggered a milestone payment of 25 million to Translate Bio. 